{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:02:48Z","timestamp":1778551368981,"version":"3.51.4"},"reference-count":17,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CCID"],"DOI":"10.2147\/ccid.s267217","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T13:30:06Z","timestamp":1654176606000},"page":"1037-1043","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic Potential of Tralokinumab in the Treatment of Atopic Dermatitis: A Review on the Emerging Clinical Data"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Katherine A","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick O","family":"Perche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-6289","authenticated-orcid":true,"given":"Steven R","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bjd.19574","volume":"184","author":"Wollenberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.anai.2020.12.004","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J Allergy Clinl Immunol"},{"key":"ref4","unstructured":"FDA approves adbry for treatment of moderate-to-severe atopic dermatitis [internet]. [cited 2022 January 23]. Available from: https:\/\/www.pharmacytimes.com\/view\/fda-approves-adbry-for-treatment-of-moderate-to-severe-atopic-dermatitis. Accessed June 1, 2022."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/bjd.20832","volume":"186","author":"Gutermuth","year":"2021","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/bjd.19573","volume":"184","author":"Silverberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jaad.2021.03.032","volume":"85","author":"Merola","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjd.20810","volume":"186","author":"Wollenberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamadermatol.2020.0796","volume":"156","author":"Drucker","year":"2020","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamadermatol.2020.1406","volume":"156","author":"Silverberg","year":"2020","journal-title":"JAMA Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8382761","volume":"2021","author":"Fadlalmola","year":"2021","journal-title":"Dermatol Res Pract"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1839008","author":"Reich","year":"2020","journal-title":"J Dermatol Treat"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","volume":"156","author":"Guttman-Yassky","year":"2020","journal-title":"JAMA Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaci.2019.08.013","volume":"145","author":"Silverberg","year":"2020","journal-title":"J Allergy Clinl Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1542\/peds.2021-053843Z","volume":"148","author":"Knox","year":"2021","journal-title":"Pediatrics"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","volume":"80","author":"Simpson","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/bjd.15493","volume":"177","author":"Saeki","year":"2017","journal-title":"Br J Dermatol"}],"container-title":["Clinical, Cosmetic and Investigational Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=81233","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=81233","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T13:30:32Z","timestamp":1654176632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/therapeutic-potential-of-tralokinumab-in-the-treatment-of-atopic-derma-peer-reviewed-fulltext-article-CCID"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":17,"URL":"https:\/\/doi.org\/10.2147\/ccid.s267217","relation":{},"ISSN":["1178-7015"],"issn-type":[{"value":"1178-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}